Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double-blind placebo-controlled trial. Danish-Swedish co-operative study group.
about
Bisphosphonates in multiple myeloma: a network meta-analysisBisphosphonates in multiple myelomaTreatment of multiple myeloma bone disease: experimental and clinical data.Bisphosphonates for the relief of pain secondary to bone metastases.Anti-tumour activity of bisphosphonates in human myeloma cells.Therapeutic options in the treatment of multiple myeloma: pharmacoeconomic and quality-of-life considerations.Bone disease in multiple myeloma: pathophysiology and management.Emerging therapies in metastatic bone pain.The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future.New insights into the pathophysiology and management of bone disease in multiple myeloma.Myeloma bone disease: pathophysiology and management.Advances in the management of myeloma bone disease.The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma.International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease.Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancer.The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network.Pathogenesis and management of myeloma bone disease.Improving progression-free and overall survival in patients with cancer: a potential role for bisphosphonates.Incidence of skeletal morbidity rates over time in patients with multiple myeloma-related bone disease as reported in randomized trials employing bone-modifying agents.Management of bone disease in multiple myeloma.Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: A systematic review within the European Association for Palliative Care guidelines project.Diagnosis and management of multiple myeloma.Bisphosphonates in multiple myeloma: an updated network meta-analysis.Comparison of five biochemical markers of bone resorption in multiple myeloma: elevated pre-treatment levels of S-ICTP and U-Ntx are predictive for early progression of the bone disease during standard chemotherapy.
P2860
Q24197839-F2CCE08D-4135-4897-99F8-BDDD48D5D57EQ24236776-716EA92D-92F7-4D07-AF59-5DC17E03A652Q30868833-B670048D-9019-43B8-815F-DC64ABF6B90AQ32139406-6817275A-DDD9-4D0A-AC80-1000477CF737Q33536291-EEA2174C-F8D5-4F9F-BA33-5BE657FA336AQ33809965-D3A30C32-D115-4AA2-961C-4F0826E0AE65Q34045789-B119B211-6548-4A97-AC7B-571829E46480Q34182919-4896B5EE-8463-4CC3-A416-7715762899E2Q35584866-2A6EBC8F-C6ED-4058-A053-ED4BBD287CEFQ35591086-897AC788-3D32-408A-871A-24FF78AA43E5Q36146493-B8372363-5FB3-4675-8479-FD99FC789751Q36327078-01BFCAC7-78CF-49A3-8BEB-BD0B3A4481A6Q36870585-DD2A3753-E451-47AA-8CF4-18C4F48DECEFQ36929923-ACC39A75-A4BE-49FC-9535-2C652AAE077DQ37355362-93ED54E6-0BE6-458D-B53E-38546DF82C5AQ37493951-FD6D2930-2DA5-481F-81BE-BBCCC8353518Q37810077-1BD849FF-530E-475A-8F9A-B3526E88A22DQ37830052-419EAD57-CB17-4829-A2D0-F064028D6F58Q38162876-562F1821-5570-49DE-959B-D6C6A9B3F5F5Q38179039-508E6D7B-1860-4F88-B16E-02F8843CA291Q38785899-3C727AA6-D3C7-4D97-8030-A85BF0F66906Q43817786-B3228C65-A117-474A-9DB3-34830900E56AQ47290135-9DE07417-9AFE-4CF7-8B6E-4B1EE13736E6Q51538830-5FA50238-8998-43FB-8384-3A48C573FED1
P2860
Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double-blind placebo-controlled trial. Danish-Swedish co-operative study group.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Failure of oral pamidronate to ...... dish co-operative study group.
@en
Failure of oral pamidronate to ...... dish co-operative study group.
@nl
type
label
Failure of oral pamidronate to ...... dish co-operative study group.
@en
Failure of oral pamidronate to ...... dish co-operative study group.
@nl
prefLabel
Failure of oral pamidronate to ...... dish co-operative study group.
@en
Failure of oral pamidronate to ...... dish co-operative study group.
@nl
P2093
P2860
P1476
Failure of oral pamidronate to ...... dish co-operative study group.
@en
P2093
Abildgaard N
Brincker H
Turesson I
P2860
P304
P356
10.1046/J.1365-2141.1998.00695.X
P407
P577
1998-05-01T00:00:00Z